secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jazz Pharmaceuticals plc (JAZZ)
CIK:        0001232524
Form:       8-K
Filed at:   2022-11-14T23:59:59+00:00
Accession:  0001193125-22-284671
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Jazz completes ex-U.S. divestiture of Sunosi to Axsome
------------------------------------------------------

- Completed ex-U.S. divestiture of Sunosi (solriamfetol) to Axsome Therapeutics on November 14, 2022.
- Earlier U.S. divestiture of Sunosi completed on May 9, 2022.
- Original deal announced on March 28, 2022; global divestiture now fully completed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1232524/000119312522284671/0001193125-22-284671-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1232524/000119312522284671/d394621d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-284671

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer